Ublituximab trials for Multiple sclerosis

All Ublituximab trials · All Multiple sclerosis trials

Phase breakdown

Recruiting trials studying Ublituximab for Multiple sclerosis

• A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)
  NCT06681623 · Phase: Not specified · Ages: 55 Years to 80 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)
  NCT07503873 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 39 locations
• Effects of Ublituximab on Motor Functions in Multiple Sclerosis
  NCT06629428 · Phase: Early Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
  NCT06864936 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
  NCT07389590 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
  NCT07220252 · Phase: Phase 2, Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · 2 locations
• Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
  NCT05877963 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 51 locations
• Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
  NCT07225361 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Ublituximab for Multiple sclerosis?

8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.